ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2023

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 149 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.

ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2023
NameSharesValueWeighting ↓
ROYCE & ASSOCIATES LP 129,836$3,317,3100.03%
Trexquant Investment LP 51,871$1,325,3040.03%
PROFUND ADVISORS LLC 22,298$569,7140.03%
WINTON GROUP Ltd 14,671$374,8440.03%
Cambria Investment Management, L.P. 14,600$373,0300.03%
Sumitomo Mitsui Trust Holdings, Inc. 1,388,574$35,478,0660.03%
Point72 Asset Management, L.P. 335,278$8,566,3530.02%
Caption Management, LLC 60,000$1,533,0000.02%
SHELL ASSET MANAGEMENT CO 21,804$5570.02%
SG Americas Securities, LLC 75,845$1,9380.02%
Schonfeld Strategic Advisors LLC 107,156$2,737,8350.02%
Rafferty Asset Management, LLC 132,781$3,392,5550.02%
Ziegler Capital Management, LLC 16,695$426,5570.02%
PRELUDE CAPITAL MANAGEMENT, LLC 8,462$216,2040.01%
Caption Management, LLC 30,000$766,5000.01%
Qube Research & Technologies Ltd 155,456$3,971,9010.01%
Snowden Capital Advisors LLC 9,377$239,5820.01%
AQR Capital Management 172,202$4,399,7610.01%
Bank Julius Baer & Co. Ltd, Zurich 58,260$1,4890.01%
Renaissance Technologies 179,700$4,5910.01%
External links

This page lists ARCTURUS THERAPEUTICS HLDGS's shareholders in Q3 2023. To view ARCTURUS THERAPEUTICS HLDGS's shareholder history, click here.